105 related articles for article (PubMed ID: 27180131)
1. Prospective study of direct radiation exposure measurements for family members living with patients with prostate (125)I seed implantation: Evidence of radiation safety.
Hanada T; Yorozu A; Shinya Y; Kuroiwa N; Ohashi T; Saito S; Shigematsu N
Brachytherapy; 2016; 15(4):412-419. PubMed ID: 27180131
[TBL] [Abstract][Full Text] [Related]
2. Radiation exposure to family and household members after prostate brachytherapy.
Michalski J; Mutic S; Eichling J; Ahmed SN
Int J Radiat Oncol Biol Phys; 2003 Jul; 56(3):764-8. PubMed ID: 12788183
[TBL] [Abstract][Full Text] [Related]
3. Radiation safety aspects of brachytherapy for prostate cancer using permanently implanted sources. A report of ICRP Publication 98.
International Commission on Radiological Protection
Ann ICRP; 2005; 35(3):iii-vi, 3-50. PubMed ID: 16330284
[TBL] [Abstract][Full Text] [Related]
4. Exposure of treating physician to radiation during prostate brachytherapy using iodine-125 seeds: dose measurements on both hands with thermoluminescence dosimeters.
Schiefer H; von Toggenburg F; Seelentag W; Plasswilm L; Ries G; Lenggenhager C; Schmid HP; Leippold T; Prikler L; Krusche B; Roth J; Engeler D
Strahlenther Onkol; 2009 Oct; 185(10):689-95. PubMed ID: 19806335
[TBL] [Abstract][Full Text] [Related]
5. Assessment of radiation safety instructions to patients based on measured dose rates following prostate brachytherapy.
Dauer LT; Zelefsky MJ; Horan C; Yamada Y; St Germain J
Brachytherapy; 2004; 3(1):1-6. PubMed ID: 15110306
[TBL] [Abstract][Full Text] [Related]
6. Radiation exposure after permanent prostate brachytherapy.
Cattani F; Vavassori A; Polo A; Rondi E; Cambria R; Orecchia R; Tosi G
Radiother Oncol; 2006 Apr; 79(1):65-9. PubMed ID: 16564593
[TBL] [Abstract][Full Text] [Related]
7. Radiation exposure of the families of outpatients treated with radioiodine (iodine-131) for hyperthyroidism.
Barrington SF; O'Doherty MJ; Kettle AG; Thomson WH; Mountford PJ; Burrell DN; Farrell RJ; Batchelor S; Seed P; Harding LK
Eur J Nucl Med; 1999 Jul; 26(7):686-92. PubMed ID: 10398815
[TBL] [Abstract][Full Text] [Related]
8. Radiation safety of receptive anal intercourse with prostate cancer patients treated with low-dose-rate brachytherapy.
Nasser NJ; Cohen GN; Dauer LT; Zelefsky MJ
Brachytherapy; 2016; 15(4):420-425. PubMed ID: 27180125
[TBL] [Abstract][Full Text] [Related]
9. Radiation dose rate variations in different measurement scenarios after prostate
Hanada T; Yorozu A; Kikumura R; Ohashi T; Shigematsu N
Brachytherapy; 2021; 20(6):1305-1311. PubMed ID: 34274244
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of physician eye lens doses during permanent seed implant brachytherapy for prostate cancer.
Penfold SN; Marcu L; Lawson JM; Asp J
J Radiol Prot; 2012 Sep; 32(3):339-47. PubMed ID: 22854245
[TBL] [Abstract][Full Text] [Related]
11. Radiation exposure to general public after permanent brachytherapy for prostate cancer.
Kono Y; Miyamoto Y; Oohashi S; Fukushi M
Radiat Prot Dosimetry; 2011 Jul; 146(1-3):229-30. PubMed ID: 21511724
[TBL] [Abstract][Full Text] [Related]
12. Less-restrictive, patient-specific radiation safety precautions can be safely prescribed after permanent seed implantation.
Dauer LT; Kollmeier MA; Williamson MJ; St Germain J; Altamirano J; Yamada Y; Zelefsky MJ
Brachytherapy; 2010; 9(2):101-11. PubMed ID: 19853532
[TBL] [Abstract][Full Text] [Related]
13. Radiation Exposure and Safety Precautions Following 131Cs Brachytherapy in Patients with Brain Tumors.
Yondorf MZ; Schwartz TH; Boockvar JA; Pannullo S; Stieg P; Sabbas A; Pavese A; Trichter S; Nedialkova L; Parashar B; Nori D; Chao KS; Wernicke AG
Health Phys; 2017 Apr; 112(4):403-408. PubMed ID: 28234701
[TBL] [Abstract][Full Text] [Related]
14. Radiation dose to family members of hyperthyroidism and thyroid cancer patients treated with 131I.
Pant GS; Sharma SK; Bal CS; Kumar R; Rath GK
Radiat Prot Dosimetry; 2006; 118(1):22-7. PubMed ID: 16105892
[TBL] [Abstract][Full Text] [Related]
15. Safety considerations during transapical aortic valve implantation.
Drews T; Pasic M; Juran R; Unbehaun A; Dreysse S; Kukucka M; Mladenow A; Hetzer R; Buz S
Interact Cardiovasc Thorac Surg; 2014 May; 18(5):574-9. PubMed ID: 24525856
[TBL] [Abstract][Full Text] [Related]
16. Radiation exposure to operating room personnel during transperineal interstitial permanent prostate brachytherapy.
Schwartz DJ; Davis BJ; Vetter RJ; Pisansky TM; Herman MG; Wilson TM; LaJoie WN; Oberg AL
Brachytherapy; 2003; 2(2):98-102. PubMed ID: 15062147
[TBL] [Abstract][Full Text] [Related]
17. Iodine-125 seed implantation (permanent brachytherapy) for clinically localized prostate cancer.
Ebara S; Katayama N; Tanimoto R; Edamura K; Nose H; Manabe D; Kobayashi T; Kobayashi Y; Kobuke M; Takemoto M; Saika T; Nasu Y; Kanazawa S; Kumon H
Acta Med Okayama; 2008 Feb; 62(1):9-13. PubMed ID: 18323866
[TBL] [Abstract][Full Text] [Related]
18. A radiation badge survey for family members living with patients treated with a (103)Pd permanent breast seed implant.
Keller BM; Pignol JP; Rakovitch E; Sankreacha R; O'Brien P
Int J Radiat Oncol Biol Phys; 2008 Jan; 70(1):267-71. PubMed ID: 17967512
[TBL] [Abstract][Full Text] [Related]
19. The retrospective analysis of the relationship between prescribed dose and risk factor for seed migration in iodine-125 prostate brachytherapy.
Hirose K; Aoki M; Sato M; Akimoto H; Hashimoto Y; Imai A; Kamimura N; Kawaguchi H; Hatayama Y; Fujioka I; Tanaka M; Ohyama C; Takai Y
Jpn J Radiol; 2016 Nov; 34(11):718-723. PubMed ID: 27631882
[TBL] [Abstract][Full Text] [Related]
20. Prospective assessment of patient-reported long-term urinary morbidity and associated quality of life changes after 125I prostate brachytherapy.
Stone NN; Stock RG
Brachytherapy; 2003; 2(1):32-9. PubMed ID: 15062161
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
